Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Understanding and Attitudes toward Cancer Clinical Trials among Patients with a Cancer Diagnosis: National Study through Cancer Trials Ireland.
Kearns C, Feighery R, Mc Caffrey J, Higgins M, Smith M, Murphy V, O'Reilly S, Horgan AM, Walshe J, McDermott R, Morris PG, Keane M, Martin M, Murphy C, Duffy K, Mihai A, Armstrong J, O'Donnell DM, Gallagher WM, Kelly CM, Kelly CM. Kearns C, et al. Among authors: gallagher wm. Cancers (Basel). 2020 Jul 16;12(7):1921. doi: 10.3390/cancers12071921. Cancers (Basel). 2020. PMID: 32708702 Free PMC article.
High Cysteinyl Leukotriene Receptor 1 Expression Correlates with Poor Survival of Uveal Melanoma Patients and Cognate Antagonist Drugs Modulate the Growth, Cancer Secretome, and Metabolism of Uveal Melanoma Cells.
Slater K, Heeran AB, Garcia-Mulero S, Kalirai H, Sanz-Pamplona R, Rahman A, Al-Attar N, Helmi M, O'Connell F, Bosch R, Portela A, Villanueva A, Gallagher WM, Jensen LD, Piulats JM, Coupland SE, O'Sullivan J, Kennedy BN. Slater K, et al. Among authors: gallagher wm. Cancers (Basel). 2020 Oct 13;12(10):2950. doi: 10.3390/cancers12102950. Cancers (Basel). 2020. PMID: 33066024 Free PMC article.
Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models.
O'Farrell AC, Jarzabek MA, Lindner AU, Carberry S, Conroy E, Miller IS, Connor K, Shiels L, Zanella ER, Lucantoni F, Lafferty A, White K, Meyer Villamandos MM, Dicker P, Gallagher WM, Keek SA, Sanduleanu S, Lambin P, Woodruff HC, Bertotti A, Trusolino L, Byrne AT, Prehn JHM. O'Farrell AC, et al. Among authors: gallagher wm. Cancers (Basel). 2020 Oct 14;12(10):2978. doi: 10.3390/cancers12102978. Cancers (Basel). 2020. PMID: 33066609 Free PMC article.
Future of biomarker evaluation in the realm of artificial intelligence algorithms: application in improved therapeutic stratification of patients with breast and prostate cancer.
Fitzgerald J, Higgins D, Mazo Vargas C, Watson W, Mooney C, Rahman A, Aspell N, Connolly A, Aura Gonzalez C, Gallagher W. Fitzgerald J, et al. J Clin Pathol. 2021 Jul;74(7):429-434. doi: 10.1136/jclinpath-2020-207351. Epub 2021 Jun 11. J Clin Pathol. 2021. PMID: 34117103 Review.
Breast cancer proteomics: clinical perspectives.
Lau TY, O'Connor DP, Brennan DJ, Duffy MJ, Pennington SR, Gallagher WM. Lau TY, et al. Among authors: gallagher wm. Expert Opin Biol Ther. 2007 Feb;7(2):209-19. doi: 10.1517/14712598.7.2.209. Expert Opin Biol Ther. 2007. PMID: 17250459 Review.
microRNAs: a new class of breast cancer biomarkers.
Mulrane L, Klinger R, McGee SF, Gallagher WM, O'Connor DP. Mulrane L, et al. Among authors: gallagher wm. Expert Rev Mol Diagn. 2014 Apr;14(3):347-63. doi: 10.1586/14737159.2014.901153. Expert Rev Mol Diagn. 2014. PMID: 24649821 Review.
248 results